Yu Xie

3.7k total citations
109 papers, 2.5k citations indexed

About

Yu Xie is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yu Xie has authored 109 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 23 papers in Cancer Research and 21 papers in Oncology. Recurrent topics in Yu Xie's work include Cancer-related molecular mechanisms research (11 papers), Cancer Immunotherapy and Biomarkers (8 papers) and RNA modifications and cancer (8 papers). Yu Xie is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), Cancer Immunotherapy and Biomarkers (8 papers) and RNA modifications and cancer (8 papers). Yu Xie collaborates with scholars based in China, United States and Germany. Yu Xie's co-authors include Beicheng Sun, Junwei Tang, Lei Deng, Runqiu Jiang, Huiling Hu, Zhanguo Wang, Qijuan Li, Wen‐Ming Chu, Yun Chen and Wei Jia and has published in prestigious journals such as Nature Communications, PLoS ONE and The FASEB Journal.

In The Last Decade

Yu Xie

104 papers receiving 2.4k citations

Peers

Countries citing papers authored by Yu Xie

Since Specialization

Citations

This map shows the geographic impact of Yu Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Xie more than expected).

Fields of papers citing papers by Yu Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Xie. The network helps show where Yu Xie may publish in the future.

Co-authorship network of co-authors of Yu Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Xie. A scholar is included among the top collaborators of Yu Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Xie. Yu Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Breaking the outer membrane barrier: structure, targets, and antimicrobial strategies for Gram-negative bacteria 2026 ·Frontiers in Microbiology ·(unknown), Yu Xie, Weiwei Yu, (unknown)	0
2	Harnessing the Power of Vibration Motors to Develop Miniature Untethered Robotic Fishes 2025 ·IEEE Robotics and Automation Letters ·(unknown), Yingying Dai, (unknown), Xiaomeng Chen, Yu Xie, Wei Zhou, Fuzhou Niu, Ying Li, Tao Luo	2
3	The Management Modality of Aseptic Loosening for Acetabular Components Along With Femur Prostheses Following Primary Hip Arthroplasty: A Reports of Four Cases 2025 ·International Medical Case Reports Journal ·(unknown), Lei Fu, Yu Xie, Xiao Yuan, Shu‐Mei Chen, (unknown)	0
4	Integrated gut microbiome and UHPLC-MS metabolomics to reveal the prevention mechanism of pidanjiangtang granules on IGT Rats 2024 ·Phytomedicine ·Yu Xie, Zirong Li, Yue Fan, Xinyi Liu, (unknown), Yanglan Gan, Zixuan Yang, Shiming Liu	2
5	Targeting xCT with sulfasalazine suppresses triple-negative breast cancer growth via inducing autophagy and coordinating cell cycle and proliferation 2024 ·Anti-Cancer Drugs ·(unknown), (unknown), (unknown), Xiao Hu, Yu Xie, (unknown), Ning Li, Yan Yan, Yue Wang, Junfang Qin	1
6	MicroRNA miR-20a-5p targets CYCS to inhibit apoptosis in hepatocellular carcinoma 2024 ·Cell Death and Disease ·(unknown), Yongfeng Hu, Hsin-Chieh Tsay, Qinggong Yuan, (unknown), Yu Xie, Renyi Qin, Michael Ott, Amar Deep Sharma, Asha Balakrishnan	10
7	Angiopoietin-like protein 8 directs DNA damage responses towards apoptosis by stabilizing PARP1-DNA condensates 2024 ·Cell Death and Differentiation ·(unknown), (unknown), (unknown), Yu Xie, Jun Wan, (unknown), (unknown), (unknown), (unknown), Hong Chen, Xinran Liu, Li Xu, Huijuan You, Desheng Hu, Robert B. Petersen, Yonghui Zhang, Ling Zheng, (unknown), Kun Huang	4
8	LINC00173 silence and estrone supply suppress ER⁺ breast cancer by estrogen receptor α degradation and LITAF activation 2024 ·Cancer Science ·Yu Xie, (unknown), Jing Yu, (unknown), Chengkun Wu, Shujing Liu, Jiayin Li, Yupeng Xiao, Yan Yan, Ning Li, Junfang Qin, Lan Lan, (unknown)	2
9	Joint-phase attention network for breast cancer segmentation in DCE-MRI 2023 ·Expert Systems with Applications ·(unknown), Zeyan Xu, Yu Xie, (unknown), (unknown), Yanfen Cui, (unknown), Chu Han, Xiaotang Yang, Zaiyi Liu, Yi Wang	23
10	Tumor Cell Derived Lnc‐FSD2‐31:1 Contributes to Cancer‐Associated Fibroblasts Activation in Pancreatic Ductal Adenocarcinoma Progression through Extracellular Vesicles Cargo MiR‐4736 2023 ·Advanced Science ·Xinglong Geng, Le Li, Yan Luo, Wenbo Yang, Jisheng Hu, Zhongjie Zhao, Chundong Cheng, Tao Zhang, Yangyang Zhang, Liwei Liu, Yu Xie, Guanqun Li, (unknown), Rui Bai, Xuewei Bai, Gang Wang, Hua Chen, Yongwei Wang, Hongze Chen, Bei Sun	23
11	Ivermectin Protects Against Experimental Autoimmune Encephalomyelitis in Mice by Modulating the Th17/Treg Balance Involved in the IL-2/STAT5 Pathway 2023 ·Inflammation ·Yu Xie, (unknown), (unknown), Wenhua Liu, Junpeng Wang	9
12	Modulation of Brain Rhythm Oscillations by Xingnao Kaiqiao Acupuncture Correlates with Stroke Recovery: A Randomized Control Trial 2022 ·Journal of Integrative and Complementary Medicine ·Xiaoli Guo, Xiaoying Zhang, Meng Sun, (unknown), Chuan Qian, (unknown), Wenli Xu, Yu Xie, Tao Xu, (unknown)	4
13	Lnc-PFAR facilitates autophagy and exacerbates pancreatic fibrosis by reducing pre-miR-141 maturation in chronic pancreatitis 2021 ·Cell Death and Disease ·(unknown), Guangquan Zhang, Wenbo Yang, Hongze Chen, Jisheng Hu, Zhongjie Zhao, Chundong Cheng, Guanqun Li, Yu Xie, Yilong Li, Rui Kong, Yongwei Wang, Gang Wang, Hua Chen, Xuewei Bai, Shangha Pan, Bei Sun, Le Li	24
14	Influence of Hormones on Sjögren’s Syndrome 2019 ·Current Pharmaceutical Design ·Yang Liu, Wei Wei, (unknown), Yu Xie, Mohammad Amjad Kamal, Jiang Li	7
15	Management Strategies for Femoral Head Replacement Arthroplasty in Uremia Patients: Case Report 2018 ·RePEc: Research Papers in Economics ·Yu Xie	1
16	Systematic Review on Acupuncture for Treatment of Dysphagia after Stroke 2017 ·Evidence-based Complementary and Alternative Medicine ·Qiuping Ye, Yu Xie, (unknown), Zhenhua Xu, Aihua Ou, Nenggui Xu	31
17	20(R)-Ginsenoside Rg3 protects SH-SY5Y cells against apoptosis induced by oxygen and glucose deprivation/reperfusion 2017 ·Bioorganic & Medicinal Chemistry Letters ·Bo He, Peng Chen, Yu Xie, Shu-De Li, Xiaochao Zhang, Renhua Yang, Guihua Wang, Shen Zhi-qiang, Hui Wang	20
18	Long non-coding RNA Myd88 promotes growth and metastasis in hepatocellular carcinoma via regulating Myd88 expression through H3K27 modification 2017 ·Cell Death and Disease ·Xiaoliang Xu, Yin Yin, Junwei Tang, Yu Xie, Zhuo Han, Xudong Zhang, Qiaoyu Liu, Xihu Qin, Xinli Huang, Beicheng Sun	28
19	Cyclophosphamide enhances anti-tumor effects of a fibroblast activation protein α-based DNA vaccine in tumor-bearing mice with murine breast carcinoma 2016 ·Immunopharmacology and Immunotoxicology ·Xia Qiu, Fei Geng, Fang-Fang Zhang, Chenlu Liu, Ping Xu, (unknown), Yu Xie, Bo Sun, Hui Wu, Bin Yu, Wei Kong, Xianghui Yu, Haihong Zhang	28
20	MUC1 and survivin combination tumor gene vaccine generates specific immune responses and anti-tumor effects in a murine melanoma model 2016 ·Vaccine ·Haihong Zhang, Chenlu Liu, Fang-Fang Zhang, Fei Geng, Xia Qiu, (unknown), Ping Xu, Yu Xie, Hui Wu, Bin Yu, Jiaxin Wu, Xianghui Yu, Wei Kong	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact